Identification and characterization of a DNA region involved in the export of capsular polysaccharide by Actinobacillus pleuropneumoniae serotype 5a.

Infection and Immunity
C K Ward, T J Inzana

Abstract

Actinobacillus pleuropneumoniae synthesizes a serotype-specific capsular polysaccharide that acts as a protective barrier to phagocytosis and complement-mediated killing. To begin understanding the role of A. pleuropneumoniae capsule in virulence, we sought to identify the genes involved in capsular polysaccharide export and biosynthesis. A 5.3-kb XbaI fragment of A. pleuropneumoniae serotype 5a J45 genomic DNA that hybridized with DNA probes specific for the Haemophilus influenzae type b cap export region was cloned and sequenced. This A. pleuropneumoniae DNA fragment encoded four open reading frames, designated cpxDCBA. The nucleotide and predicted amino acid sequences of cpxDCBA contained a high degree of homology to the capsule export genes of H. influenzae type b bexDCBA, Neisseria meningitidis group B ctrABCD, and, to a lesser extent, Escherichia coli K1 and K5 kpsE and kpsMT. When present in trans, the cpxDCBA gene cluster complemented kpsM::TnphoA or kpsT::TnphoA mutations, determined by enzyme immunoassay and by restored sensitivity to a K5-specific bacteriophage. A cpxCB probe hybridized to genomic DNA from all A. pleuropneumoniae serotypes tested, indicating that this DNA was conserved among serotypes. These data sug...Continue Reading

References

Jan 1, 1979·Annual Review of Genetics·M Rosenberg, D Court
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Oct 11, 1992·Protein Science : a Publication of the Protein Society·J ReizerM H Saier
Jun 1, 1992·The Journal of Infectious Diseases·J S Kroll
Jul 1, 1992·Canadian Journal of Microbiology·K Jann, B Jann
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M FroschT F Meyer
Jul 11, 1988·Nucleic Acids Research·W J DowerC W Ragsdale
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J Shine, L Dalgarno
Jul 10, 1981·Nucleic Acids Research·D Ish-Horowicz, J F Burke
Apr 25, 1983·Nucleic Acids Research·D K Hawley, W R McClure
May 5, 1982·Journal of Molecular Biology·J Kyte, R F Doolittle
Mar 1, 1993·Microbiological Reviews·A P Pugsley
Dec 1, 1993·Microbiological Reviews·M J Fath, R Kolter

❮ Previous
Next ❯

Citations

Aug 7, 2003·Expert Review of Vaccines·Sims K KochiUna S Ryan
May 23, 2003·Infection and Immunity·Aloka B BandaraThomas J Inzana
Sep 2, 2010·Microbiology and Molecular Biology Reviews : MMBR·Leslie CuthbertsonChris Whitfield
Jul 30, 2020·Scientific Reports·Hugo F AzurmendiWillie F Vann
Oct 14, 1998·FEMS Microbiology Letters·J Y ChungB Adler
Sep 26, 2006·FEMS Immunology and Medical Microbiology·Trevor K Wagner, Martha H Mulks
Nov 16, 2001·Animal Health Research Reviews·J D DubreuilM Gottschalk
May 20, 2008·The Veterinary Record·L ZhouP R Langford
Sep 15, 2004·Journal of Clinical Microbiology·Jennifer A SchuchertS Jessing
Jun 10, 1998·Journal of Clinical Microbiology·T M LoT J Inzana
Nov 14, 1997·Infection and Immunity·T J InzanaM A Apicella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.